Estimated to impact at least 125 million people worldwide, the burden of living with psoriasis runs more than skin deep. From the physical impact and comorbidities to the emotional toll that may plague everyday life, many patients still struggle with inadequate disease control, often going untreated or undertreated, despite the myriad treatment options available. There is a significant need for new psoriasis treatment options, and this interactive program is designed to provide expert interpretation of new and emerging data on the treatment of psoriasis, with multidisciplinary expert perspectives on how new agents can impact clinical practice. This podcast will discuss how to help clinicians select the most appropriate treatment as well as address the significant health burdens and comorbidities experienced by many patients with psoriasis.

Launch Date: August 15, 2024

Release Date: August 15, 2024

Expiration Date: July 31, 2025

FACULTY

Bruce Strober, MD, PhD

Clinical Professor

Yale University and Central Connecticut University

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/optimizing-outcomes-in-psoriasis-exploring-the-impact-of-rapid-diagnosis-and-emerging-therapeutic-agents